Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 09/04/2012 12:55 PM EDT
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment Program will be posting a draft technology assessment for review on September 7, 2012. This draft is entitled "Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin."
If you are interested in reviewing this document, please visit: http://www.ahrq.gov/clinic/ta/tareview.htm. The document will be available for review from 9:00 AM on September 7, 2012, to 5:00 PM on September 21, 2012.
If you have any questions, please contact ahrqtap@ahrq.hhs.gov.
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program develops systematic reviews, health technology assessments, and other reports at the request of the Centers for Medicare & Medicaid Services (CMS) Coverage and Analysis Group. These reports are funded by an Interagency Agreement from CMS to AHRQ and used to inform national coverage policies, discussion at public Medicare Evidence Development and Coverage Advisory Committee (MedCAC) meetings, and/or for other policy considerations.
To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the AHRQ Effective Health Care E-mail distribution list 1 week before the posting of draft reports. Each report will be available for public review on this Web site for a total of 2 weeks.
AHRQ's TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program Web site at http://www.ahrq.gov/clinic/techix.htm within 3 months after the associated final report is posted on this Web site. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.
Note: Comments received after the review period will not be accepted.
Date Available: 9:00 AM, September 7, 2012, to 5:00 PM, September 21, 2012
Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin
Date Available: 9:00 AM, September 7, 2012, to 5:00 PM, September 21, 2012
If you are interested in reviewing this document, please visit: http://www.ahrq.gov/clinic/ta/tareview.htm. The document will be available for review from 9:00 AM on September 7, 2012, to 5:00 PM on September 21, 2012.
If you have any questions, please contact ahrqtap@ahrq.hhs.gov.
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program develops systematic reviews, health technology assessments, and other reports at the request of the Centers for Medicare & Medicaid Services (CMS) Coverage and Analysis Group. These reports are funded by an Interagency Agreement from CMS to AHRQ and used to inform national coverage policies, discussion at public Medicare Evidence Development and Coverage Advisory Committee (MedCAC) meetings, and/or for other policy considerations.
To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the AHRQ Effective Health Care E-mail distribution list 1 week before the posting of draft reports. Each report will be available for public review on this Web site for a total of 2 weeks.
AHRQ's TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program Web site at http://www.ahrq.gov/clinic/techix.htm within 3 months after the associated final report is posted on this Web site. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.
Review Steps
When a draft Technology Assessment report is available for review, you may review the draft report by completing the associated review form and then selecting "Submit" on the form.Note: Comments received after the review period will not be accepted.
Currently Available for Review
No draft technology assessments are available at this time.Available Soon
Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing for Chromosomal Damage in Uterine Cervical Cells to Predict Potential for Dysplasia/MalignancyDate Available: 9:00 AM, September 7, 2012, to 5:00 PM, September 21, 2012
Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin
Date Available: 9:00 AM, September 7, 2012, to 5:00 PM, September 21, 2012
Questions
Please contact ahrqtap@ahrq.hhs.gov if you have any questions.Current as of September 2012
Internet Citation:
Call for Public Review. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/ta/tareview.htm
No hay comentarios:
Publicar un comentario